Diversity's Pandemic Distractions

Area of Science:

• Public Health
• Sociology of Health
• Medical Ethics

Background:

• Pandemic diseases, including COVID-19, have a history of being racialized, often through overt and subtle discriminatory practices.
• Racial disparities in COVID-19 incidence and mortality became evident early on, prompting explanations that leaned towards genetic differences.
• Calls for racial "diversification" in vaccine clinical trials, while seemingly well-intentioned, risked reinforcing genetic frames of racial difference.

Purpose of the Study:

• To explore how the concept of "diversity" racialized responses to COVID-19.
• To analyze the implications of this racialization for understanding and addressing race-based health disparities.
• To critically examine the geneticization of racial disparities in health and its impact on equitable pandemic response.

Main Methods:

• Analysis of the "geneticization" of COVID-19 racial disparities.
• Examination of the rationales and merits of racial "diversification" in clinical trials.
• Review of historical and structural factors contributing to health inequities.

Main Results:

• Initial responses to COVID-19 disparities focused on genetic differences, diverting attention from social and political determinants.
• Racial diversification in vaccine trials, though achieving short-term enrollment goals, reinforced genetic notions of race.
• The vaccines demonstrated similar safety and efficacy across racial groups, undermining the genetic rationale for trial diversity.

Conclusions:

• An uncritical embrace of "diversity" in biomedical contexts can distract from structural causes of health injustice.
• The geneticization of racial disparities reinforces false ideas of biological difference, hindering efforts toward racial justice.
• Addressing health disparities requires a focus on historical and structural forces, not solely on biological or genetic explanations.